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Abstract
Introduction: Oncological implications of laparoscopic resection in primary hepatic malignancy are not
well defined. Laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) in comparison to an
open liver resection (OLR) in peri-operative and long-term oncological outcomes are described from a
single North American institution.
Methods: From 2006 to 2013, all forty-three LLR patients for HCC were evaluated. Each patient was
matched to two OLR patients for age at operation, maximal tumour size and tumour number.
Results: When compared with OLR, LLR had a lower severity of complication (0% versus 27%,
P = 0.050) and lower 30-day readmission rate (2.3% versus 18.6%, P = 0.010). The length of stay (LOS)
was shorter in LLR patients (5 versus 7 days, P < 0.001) and the estimated blood loss was also lower in
LLR (300 versus 700 ml, P = 0.004). Admission to intensive care unit (ICU), emergency room (ER) visits
and complication rates were similar. Overall, recurrence-free and intra-hepatic recurrence-free survival
were comparable between LLR and OLR.
Discussion: LLR confers the widely-accepted benefits of laparoscopic surgery, namely severity of
complication, 30-day readmission rate, LOS and blood loss. Further studies are required to examine intra-
and extra-hepatic recurrence after LLR. LLR for HCC should be considered for appropriately selected
patients in centres with requisite volume and expertise.
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Introduction
Hepatocellular carcinoma (HCC) is the most common solid
tumour in the world and the third leading cause of cancer-related
death.1 In recent years, there has been a clear increase in HCC
incidence in North America as a result of a multitude of factors
including trends in the prevalence of predisposing conditions
including non-alcohol-related fatty liver disease as well as hepati-
tis B and C infections.2,3 Curative options for HCC include surgi-
cal resection and liver transplantation. In the majority of North
American centres, liver transplantation is reserved for patients
with advanced cirrhosis and early HCC that meet regional trans-
plantation guidelines.4 In contrast, hepatic resection may be
considered as a primary therapy in patients with HCC and
well-preserved liver function. Indeed, a resection may also be per-
formed in patients with cirrhosis with well-persevered hepatic
function who have been deemed unsuitable for, or declined, a liver
transplantation.5
The surgical management of HCC is complicated by the con-
comitant management of two disease processes, the primary
malignancy and the underlying liver disease. To date, an open liver
resection (OLR) has been the accepted standard operative
approach for resectable HCC. Owing to the presence of underly-
ing liver disease, patients with HCC undergoing OLR are at a high
risk of developing significant post-operative complications com-
pared with open liver resections for other indications.6 A
laparoscopic liver resection (LLR) offers a less-invasive alternative
to OLR and may therefore be of particular benefit in this patient
population. LLR has been slow to gain widespread traction
because of the relative technical complexity and dearth of formal
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training; however, recent data reveal that an increasing number of
centres are implementing LLR for both benign and malignant
liver lesions.7 Emerging data suggest that LLR is safe,8 however,
whereas its role in the treatment of benign and metastatic disease
is well described, its application to primary hepatic malignancy is
not well defined and the oncological outcomes are not clear. The
aim of this study was to compare the outcomes of HCC patients
with LLR versus OLR on a 2-to-1 matched-case basis.
Patients and methods
Study design and patient selection
Ethical approval for this study was granted by the institutional
research ethics board at the University Health Network. A pro-
spectively maintained database of all hepatic resections was inter-
rogated to identify all patients who underwent a primary liver
resection for HCC. Forty-three patients who underwent a liver
resection for HCC were identified during the period from 30 May
2007 to 18 October 2013. Previous studies have demonstrated that
variables including tumour size, tumour number and age are
independent risk factors for survival, based on multivariate
analysis.9–11 Thus, each patient was matched to two patients who
received OLR according to the age at operation within 15 years,
tumour size within 2.5 cm and tumour number was matched for
solitary or multifocal tumours. All resections were performed by a
specialist hepato-pancreatobiliary (HPB) surgeon at a university
teaching centre.
Upon diagnosis of HCC, all patients were staged with mul-
tiphasic computed tomography (CT) of the chest and abdomen. If
necessary, contrast-enhanced ultrasound (CEUS) and or mag-
netic resonance (MR) imaging were employed to confirm the
diagnosis of HCC as per the AmericanAssociation for the Study of
Liver Diseases (AASLD) guidelines.4 All HCC patients were dis-
cussed at weekly multidisciplinary conferences consisting of HPB
surgical oncologists, hepatologists, medical and radiation oncolo-
gists and interventional radiologists. In general, a liver resection
was recommended for solitary lesions greater than 2 cm with
well-preserved liver function as defined by Child–Pugh Class
(A/B) and evidence of limited portal hypertension (platelet count
> 100 000/μl, or hepatic venous pressure gradient <10 mmHg).
Ablation was recommended as a definitive treatment for small,
solitary HCC ≤2 cm. Liver transplantation was recommended for
patients with multifocal HCC or decompensated cirrhosis.
Patients with resectable multifocal lesions who were ineligible for,
or declined transplantation, were offered a surgical resection.
Surgical technique
The technique employed for LLR has been described previously.12
In general, the approach to bothOLR and LLRwas similar.Amajor
anatomical resection was reserved for larger tumours or where
major vascular relations mandated a formal anatomical resection.
For the purpose of parenchymal sparing, a non-anatomical and
segmental resection was performed when an adequate margin
could confidently bepredicted. Inflowocclusionwasobtained in all
LLR andOLR lobectomies before parenchymal transection. Stand-
ard vascular stapling devices were used in bothOLR and LLRwhen
required. Water-jet dissection was used for parenchymal
transection in all OLR and major (> 3 segments) LLR patients
(Helix Hydrojet, ERBE and AMT Electrosurgery). Ultrasonic
shears were used for parenchymal transection in all laparoscopic
patients.13
Clinical outcomes
Patient demographics, including gender, age at resection and
Child–Pugh classification, were recorded. Peri-operative out-
comes included complication rate, severity of complications based
on Clavien–Dindo classification,14 type of hepatic resection, esti-
mated blood loss, admission to the intensive care unit (ICU),
30-day readmission rate, emergency room (ER) visits within
3 months, resection margin, length of stay (LOS), incision to
closure time and conversion rate. Histological analysis of resected
HCC specimens was also assessed, including underlying liver
disease, WHO histological grade, microvascular invasion, liver
fibrosis based on Laennec classification,15 tumour number and
maximal tumour diameter.
Follow-up, survival and recurrence
After resection, patients were followed every 3 months in the first
two post-operative years and then at 4-month intervals for post-
operative years 3–5 with contrast-enhanced CT imaging of the
abdomen and chest and or ultrasound (US). Suspected recurrence
was further investigated with contrast enhanced CT, CEUS or
MRI to confirm the diagnosis of HCC per AASLD criteria. After
5 years, patients returned to normal screening with US performed
at 6-monthly intervals as per AASLD guidelines.4
The overall survival (OS) was calculated from the day of
surgery until the day of death or last contact. The recurrence-free
survival of patients who recurred was defined as the time from the
day of surgery to the day of imaging study that confirmed tumour
recurrence. For patients who did not develop recurrent disease,
the day of surgery to the day of death or last contact was used.
Statistical analysis
Descriptive statistics were reported as median and range for con-
tinuous variables and as a number and percentage for discrete
variables. The chi-square test or Fisher’s exact test, where appro-
priate, was conducted to compare discrete variables between
groups. TheMann–WhitneyU-test was conducted for continuous
variables, such as tumour margin and tumour diameter. Overall
survival and recurrence-free survival were calculated by the
Kaplan–Meier method and differences were compared by the log-
rank test. The Cox-regression test was used for univariate and
multivariate analysis using a confidence interval of 95%. Statistical
significance was defined as P < 0.05. Statistical analysis was carried
out using SPSS software (version 20; SPSS, Chicago, IL, USA).
HPB 2015, 17, 304–310
HPB 305
© 2014 International Hepato-Pancreato-Biliary Association
Table 1 Patient demographics, peri- and post-operative course of patients who underwent laparoscopic and open liver resections for
hepatocellular carcinoma
LLR
n = 43 (%)
OLR
n = 86 (%)
Combined
n = 129 (%)
P-value
Gender 0.110
Male 29 (67.4) 69 (80.2) 98 (76.0)
Female 14 (32.6) 17 (19.8) 31 (24.0)
Age at resection (years; median, range) 62.0 (30–86) 63.0 (34–84) 62.9 (30–86) 0.521
Underlying liver disease 0.100
HBV 19 (44.2) 52 (60.5) 71 (55.0)
HCV 13 (30.2) 18 (20.9) 31 (24.0)
Other (NASH, alcohol, undetermined) 11 (25.6) 16 (18.6) 27 (20.9)
Child–Pugh 0.789
A 41 (97.6) 81 (97.6) 122 (97.6)
B 1 (2.4) 2 (2.4) 3 (2.4)
Not available 1 3 4
Clavien–Dindo Classification 0.050
Non-severe (Grade 1–2) 10 (100.0) 24 (72.7) 34 (79.1)
Severe (Grade 3–4) 0 (0.0) 9 (27.3) 9 (20.9)
No complication 32 52 84
Not available 1 1 2
Type of hepatic resection
1–2 segments 21 (48.8) 45 (52.3) 66 (51.2) 0.740
2 + segments 22 (51.2) 41 (47.7) 63 (48.8)
Resection margin 1.000
Positive 0 (0.0) 0 (0.0) 0 (0.0)
Negative 43 (100.0) 86 (100.0) 129 (100.0)
Not available 0 0 0
Estimated blood loss (ml; median, range) 300 (0–6500) 700 (0–3500) 600 (0–6500) 0.004
Incision to closure time (min; median, range) 170 (88–536) 197 (70–365) 194 (88–536) 0.610
Complications 0.067
Yes 10 (23.3) 34 (39.5) 44 (34.1)
No 33 (76.7) 52 (60.6) 85 (65.9)
Conversion
Yes 6 (14.0) NA NA NA
No 37 (86.0)
Admission to ICU 0.657
Yes 3 (7.0) 8 (9.3) 11 (8.5)
No 40 (93.0) 78 (90.7) 118 (91.5)
30-day readmission 0.010
Yes 1 (2.3) 16 (18.6) 17 (13.2)
No 42 (97.7) 70 (81.4) 112 (86.8)
ER visit in 3 months 0.267
Yes 2 (4.7) 9 (10.5) 11 (8.5)
No 41 (95.3) 77 (89.5) 118 (91.5)
Length of stay (days; median, range) 5 (3–51) 7 (5–77) 7 (3–77) <0.001
OLR, open liver resection; HBV, hepatitis B virus;HCV, hepatitis C virus; NASH, non-alcoholic steatohepatitis; ICU, intensive care unit.
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Results
Demographics and peri-operative outcomes are shown in Table 1.
Six out of 43 patients required conversion from a laparoscopic to
open resection. All of these occurred in the first 3 years of the
study and there were no conversions in subsequent years. Five of
the six patients were converted as a result bleeding, whereas one
patient was converted because of unanticipated anatomical con-
siderations. Three patients in the LLR group had evidence of
recent rupture but no evidence of peritoneal disease at the time of
resection.
There were 18/43 and 33/86 cirrhotic patients in the LLR and
OLR groups, respectively (Table 2). There was no statistical differ-
ence between these groups with respect to age at resection, type of
resection, complication rate, ER visits within 3 months, resection
margin, gender, 30-day readmission rate and severe complica-
tions. However, compared with the OLR group, the LLR group
had a lower rate of ICU admission (0% versus 12%, P = 0.012),
lower estimated blood loss (250 versus 800 ml, P = 0.015) and
shorter LOS (6 versus 7 days, P = 0.018)
The median follow-up was 44.4 months for the OLR group
and 22.7 months for the LLR group. The overall survival at 1, 3
and 5 years for LLR was 95.3%, 89.7% and 89.7%, respectively,
and 93.9%, 89.5% and 87.3%, respectively, for OLR. Overall sur-
vival was similar (P = 0.899) and there was no statistical difference
in the recurrence-free survival between the groups (P = 0.119)
(Fig. 1). The 1-, 3- and 5-year recurrence-free survival was 60.5%,
53.5% and 53.5%, and 81.5%, 66.7% and 58.6% for the LLR and
OLR groups, respectively. A subgroup analysis of the cirrhotic
patients is illustrated in Fig. 2. Again, there was no statistical dif-
ference between the LLR and OLR groups in terms of overall
survival (P = 0.173) and recurrence-free survival (P = 0.118). It is
important to note that the numbers at risk in the LLR group at 5
years was low and should be interpreted with caution.
The intra-hepatic recurrence-free survival at 1, 3 and 5 years
was 68.2%, 60.3%, 60.3% for LLR and 85.0%, 73.1% and 64.3%
for OLR (P = 0.139). Also, the extra-hepatic recurrence-free sur-
vival was 85.1%, 85.1% and 85.1% for LLR and 97.4%, 92.8% and
92.8% for OLR patients (P = 0.210).
Discussion
Surgical resection of HCC offers an excellent prospect of both
overall- and disease-free survival in non- and mildly-cirrhotic
patients. The outcomes reported in this series are commensurate
with the highest standards reported to date.16–18 In spite of the
Table 2 Histological analysis of hepatocellular carcinoma in patients who underwent laparoscopic and open liver resections for hepatocel-
lular carcinoma
LLR
n = 43 (%)
OLR
n = 86 (%)
Combined
n = 129 (%)
P-value
Histological grade 0.541
Well differentiated 2 (5.0) 5 (6.0) 7 (5.6)
Moderately differentiated 29 (72.5) 64 (76.2) 93 (75.0)
Poorly differentiated 9 (22.5) 15 (17.9) 24 (19.4)
Not available 3 2 5
Microvascular invasion 0.350
Yes 21 (52.5) 37 (43.5) 58 (46.4)
No 19 (47.5) 48 (56.5) 67 (53.6)
Not available 3 1 4
Liver fibrosis stage (Laennec classification) 0.930
0 1 (2.4) 1 (1.2) 2 (1.6)
1 7 (17.1) 11 (12.9) 18 (14.3)
2 8 (19.5) 17 (20.0) 25 (19.8)
3 7 (17.1) 23 (27.1) 30 (23.8)
4 18 (43.9) 33 (38.8) 51 (40.5)
Not available 2 1 3
Tumour number 0.989
1 41 (95.3) 81 (95.3) 122 (95.3)
>1 2 (4.7) 4 (4.7) 7 (4.7)
Not available 0 1 1
Greatest tumour diameter (cm; median, range) 5.4 (2–16) 4.4 (2–14) 4.8 (2–16) 0.189
Margin distance (cm; median, range) 1.3 (0.10-6.00) 1.0 (0.04–8) 1.0 (0.04–8.00) 0.250
LLR, laparoscopic liver resection; OLR, open liver resection.
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Months 6 12 18 24 30 36 42 48 54 60 
LLR 28 19 14 11 10 9 7 5 1 1 
OLR 74 66 59 50 49 44 38 33 22 18 
Months 6 12 18 24 30 36 42 48 54 60 
LLR 28 19 14 11 10 9 7 5 1 1 

























Figure 1 Overall survival, recurrence-free survival, intra-hepatic recurrence-free survival and extra-hepatic recurrence-free survival according
to laparoscopic or open liver resection for hepatocellular carcinoma (P = 0.899, 0.119, 0.139 and 0.210, respectively). LLR, laparoscopic liver
resection; OLR, open liver resection.
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increasing ubiquity of laparoscopy, its adoption in liver resection
has been slower than in other subspecialties. In the setting of
chronic liver disease, many centres are reluctant to employ a
laparoscopic resection owing to what were, initially, well-founded
technical concerns. However, there is now a growing body of
literature to support the safety and adequacy of LLR in the setting
of benign and metastatic disease.19–23 This study sought to
examine the utility of LLR for HCC compared with OLR in a
single, large volume, North American institution.
In two, well-matched groups of patients, LLR is associated with
oncological outcomes similar to those of OLR at intermediate
follow-up. The short-term benefits of laparoscopic surgery in
terms of post-operative pain and return to normal activity are well
recognized, but what is not clear in the context of LLR for malig-
nant disease, is medium- to long-term oncological outcome. This
study demonstrates that LLR is associated with oncological out-
comes similar to OLR and in keeping with the best reported data.24
Overall survival appears equivalent after LLR and OLR;
however, there appears to be a non-significant trend suggesting a
potentially higher intra-hepatic recurrence rate after LLR in this
series. While patients were matched on known pre-operative
tumour and patient factors (age, tumour size and tumour
number) these outcomes are notable given the potentially higher
rates of poorly-differentiated, large-size lesions and microvascular
invasion within the LLR cohort, factors typically associated with
reductions in both disease-free and overall survival.25 While
margin status is similar between LLR and OLR, it is acknowledged
that there may be a predilection towards non-anatomic resections
in LLR. Previous open resection series have demonstrated that
non-anatomic resections is associated with higher intra-hepatic
recurrence rates compared with anatomic resections.26 Finally,
HCV was a more common predisposing condition in the LLR
group and some series have suggested a higher recurrence rate
among HCV patients compared with other liver disease aetiolo-
gies.12 Therefore, while the LLR and OLR groups were matched on
selected pre-operative factors, some imbalances in the surgical
approach, patient factors and histological findings may have led to
a higher intra-hepatic recurrence rate in this series. Given the
relatively small sample size and design of this study, these trends
should be interpreted with caution and are worthy of further
investigation. In particular, the discrepancy in length of follow-up
between groups must be considered.While outcomes at a median
follow-up of 22.7 months in the LLR group are comparable to the
OLR group, it must be recognized that survival may drop-off
further over time. This will be carefully assessed in further reports.
Typically of studies comparing laparoscopic and open surgery,
reductions in LOS, estimated blood loss, readmission rate and
ER attendance in the LLR group compared with OLR were
Figure 2 Overall survival and recurrence-free survival in cirrhotic patients (P = 0.173 and 0.118, respectively)
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demonstrated. Furthermore, LLR was associated with a signifi-
cantly lower rate of severe peri-operative complications compared
with OLR. It is reasonable to suggest that this reduction in com-
plications may be attributed to the minimally-invasive approach.
It is also worth noting that this cohort of patients was accrued
during the early experience of LLR at the institution. During the
study period, the 6 patients converted to OLR from LLR occurred
in the first 3 years and there have been no further conversions
since then. This suggests that as the learning curve is overcome,
further improvements may be expected.
The obvious limitations of the study are the single-centre,
retrospective nature of the analysis and the inherent difficulties
with matching studies. While the cohort size might be considered
small in certain contexts, this cohort actually represents one of the
largest reported to date from a North American centre. Although
HCC remains relatively rarer in North America than elsewhere,
this institution has a sizeable HCC practice. It was demonstrated
that excellent outcomes can be achieved with LLR for HCC, com-
parable with those achieved with OLR. In addition, LLR offers
significant benefits in terms of peri-operative outcomes compared
with OLR and suggest that in appropriate centres, LLR should be
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